Galli, Eugenio
 Distribuzione geografica
Continente #
NA - Nord America 2.196
AS - Asia 2.160
EU - Europa 2.097
SA - Sud America 402
AF - Africa 55
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.913
Nazione #
US - Stati Uniti d'America 2.106
SG - Singapore 932
CN - Cina 484
IT - Italia 415
DE - Germania 378
NL - Olanda 359
BR - Brasile 332
VN - Vietnam 253
SE - Svezia 178
FI - Finlandia 171
FR - Francia 170
PL - Polonia 151
IN - India 102
GB - Regno Unito 72
JP - Giappone 72
BD - Bangladesh 61
CA - Canada 46
ID - Indonesia 46
IE - Irlanda 45
HK - Hong Kong 42
KR - Corea 39
RU - Federazione Russa 33
MX - Messico 30
AT - Austria 24
CZ - Repubblica Ceca 23
AR - Argentina 21
ES - Italia 20
IQ - Iraq 18
SA - Arabia Saudita 17
TR - Turchia 16
BE - Belgio 14
CO - Colombia 12
EC - Ecuador 12
UZ - Uzbekistan 11
ZA - Sudafrica 11
VE - Venezuela 10
CI - Costa d'Avorio 9
MA - Marocco 9
UA - Ucraina 9
IL - Israele 7
KE - Kenya 7
LT - Lituania 7
PK - Pakistan 7
JO - Giordania 6
IR - Iran 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
KZ - Kazakistan 4
LB - Libano 4
NP - Nepal 4
BO - Bolivia 3
BY - Bielorussia 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
KG - Kirghizistan 3
KW - Kuwait 3
OM - Oman 3
PH - Filippine 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
PR - Porto Rico 2
PY - Paraguay 2
QA - Qatar 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 6.910
Città #
Singapore 530
Amsterdam 348
San Jose 320
Ashburn 211
Munich 155
Frankfurt am Main 150
Warsaw 144
Rome 139
Chandler 129
Hefei 108
Helsinki 103
Beijing 94
Los Angeles 79
St Louis 76
The Dalles 74
New York 72
Tokyo 71
Hanoi 70
Ho Chi Minh City 67
Lauterbourg 66
Chicago 64
Milan 62
Council Bluffs 58
Hyderabad 58
Dublin 41
Hong Kong 39
Seoul 39
Dallas 37
Jakarta 36
Florence 35
Kent 34
Santa Clara 34
Lappeenranta 33
Fairfield 31
Turku 27
London 23
Seattle 23
Brooklyn 22
São Paulo 21
Paris 20
Nuremberg 19
Orem 19
Boardman 18
Toronto 18
Buffalo 17
Da Nang 16
Montreal 16
Brno 15
Chennai 15
Moscow 15
Bremen 14
Brussels 14
Houston 14
Wilmington 14
Atlanta 13
Boston 13
Düsseldorf 13
Marseille 13
Woodbridge 13
Belo Horizonte 12
Mexico City 12
Princeton 12
Tashkent 11
Vienna 11
Manchester 10
Phoenix 10
Rio de Janeiro 10
San Mateo 10
Abidjan 9
Campinas 9
Charlotte 9
Denver 9
Haiphong 9
Miami 9
Poplar 9
Redmond 9
Stockholm 9
Falls Church 8
Guangzhou 8
Johannesburg 8
Shanghai 8
Baghdad 7
Tampa 7
Bogotá 6
Cambridge 6
Caracas 6
Casablanca 6
Catania 6
Cattolica 6
Curitiba 6
Jeddah 6
Nairobi 6
Naples 6
New Delhi 6
Portsmouth 6
Riyadh 6
Tianjin 6
Amman 5
Biên Hòa 5
Bovisio-Masciago 5
Totale 4.356
Nome #
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 587
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 302
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 285
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 235
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 151
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 150
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 146
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 141
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 138
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 129
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 125
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 122
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 120
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 120
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 119
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 118
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 117
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 115
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 111
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 111
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 110
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 110
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 107
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 107
CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL) 107
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 107
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 106
Coagulopathy in CAR-T: Critical concern or mere blip? 106
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 106
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 105
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 103
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 102
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 101
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 100
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 97
Vascular inflammation in patients undergoing anti-CD19 chimeric antigen receptor-T cells for haematologic malignancies: a call for cardiovascular surveillance 92
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 91
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 90
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 90
Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma 89
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 87
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 85
G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma 82
Prognostic factors in hodgkin lymphoma 82
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma 81
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 80
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT 80
Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant 74
VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation 71
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 70
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 67
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 66
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 62
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma 61
Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS) 56
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? 52
Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T 45
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study 45
Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy 40
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 38
Frail is not fail: Limited impact of comorbidities on non‐relapse mortality and safety in patients with LBCL treated with CAR‐T 37
Cinnamon-enriched chocolate pralines as a delivery system for Lacticaseibacillus rhamnosus CRL1505: viability and digestive stability 33
Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy 32
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 30
Clinical features and management of LICATS involving the heart in a patient with diffuse and rapidly progressive systemic sclerosis 13
Platelet recovery delay and survival in patients with myelofibrosis undergoing allogeneic hemopoietic stem cell transplantation 4
Deciphering the Complex Intertwining Between Cytopenia and Transfusion Needs After CAR-T-Cell Therapy for B-Cell Malignancies 1
Totale 7.043
Categoria #
all - tutte 26.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022135 9 5 5 5 14 8 3 14 6 6 27 33
2022/2023450 74 51 17 68 30 54 35 27 48 21 23 2
2023/2024412 10 72 28 42 6 52 30 38 7 34 34 59
2024/20251.806 40 30 79 172 119 96 124 79 190 172 424 281
2025/20263.936 428 143 224 342 473 651 568 207 277 314 150 159
Totale 7.043